Highlights
NASDAQ: AYTU       Aytu Bioscience Inc
Last Price Today's Change   Day's Range   Trading Volume
0.83   -0.15 (15.31%)  0.80 - 0.924  333,800

Overview

 
Avg Volume (4 weeks):103,220
4 Weeks Range:0.80 - 1.29
4 Weeks Price Volatility (%):
6.12%
52 Weeks Range:0.68 - 2.61
52 Weeks Price Volatility (%):
7.77%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Aytu BioScience Inc is a commercial-stage healthcare company focused on acquiring, developing and commercializing products in the field of urology. It focuses on hypogonadism, prostate cancer, urinary tract infections and male infertility. The company markets ProstaScint (capromab pendetide), a radio-imaging agent indicated to detect the prostate-specific membrane antigen (PSMA) in the assessment and staging of prostate cancer. Other products of the company include MiOXSYS, a novel in vitro diagnostic device, Natesto (testosterone) nasal gel, and Fiera Personal Care Device. The company, through its wholly-owned subsidiary Nuelle, Inc, is also focused on women’s sexual wellbeing and intimacy.

  Be the first to like this.
 


 

4308  3684  701  236 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CHK 0.70+0.01 
 EEM 43.13+0.34 
 AMD 38.56+0.21 
 SPY 311.79+2.24 
 ACB 2.73-0.56 
 AIHS 1.07+0.65 
 AMRN 24.02+2.53 
 FCEL 0.825-0.064 
 TVIX 7.12-0.71 
 UBER 26.79+0.80 
Partners & Brokers